SKI Market

Indian Indices

Sensex

81,031.41 308.47
( 0.38%)

Global Indices

Nasdaq

48,928.31 -164.26
(-0.33%)

Dow Jones

6,963.16 -26.85
(-0.38%)

Hang Seng

53,392.10 16.50
(0.03%)

Nikkei 225

10,214.90 43.14
(0.42%)

Forex

USD-INR

91.66 -0.27
(-0.29%)

EUR-INR

108.61 -1.36
(-1.24%)

GBP-INR

125.41 -1.53
(-1.21%)

JPY-INR

0.59 -0.01
(-1.35%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Venus Remedies Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

526953

INE411B01019

467.2458657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VENUSREM

15.73

1111.4

EPS(TTM)

Face Value()

Div & Yield %

52.85

Back

Antarctica reports standalone net profit of Rs 0.40 crore in the September 2025 quarter

Nov 15,2025

Net profit of Antarctica reported to Rs 0.40 crore in the quarter ended September 2025 as against net loss of Rs 0.20 crore during the previous quarter ended September 2024. Sales rose 1150.00% to Rs 5.00 crore in the quarter ended September 2025 as against Rs 0.40 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5.00	0.40	1150
OPM %	19.60	-45.00	-
PBDT	0.98	-0.18	LP
PBT	0.78	-0.20	LP
NP	0.40	-0.20	LP

81,031.41 308.47 ( 0.38%)

48,928.31 -164.26 (-0.33%)

6,963.16 -26.85 (-0.38%)

53,392.10 16.50 (0.03%)

10,214.90 43.14 (0.42%)

91.66 -0.27 (-0.29%)

108.61 -1.36 (-1.24%)

125.41 -1.53 (-1.21%)

0.59 -0.01 (-1.35%)